Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Featured trial
Adult and Adolescent Participants with Inadequately Controlled Asthma

This is a variable length study to evaluate the efficacy and safety of a new triple therapy inhaler (Budesonide/Glycopyrronium/Formoterol) in adults and adolescents with severe asthma

  • 0 views
  • 04 Jan, 2022
  • 1 location
Featured trial
  • 0 views
  • 28 Jun, 2022
  • 1 location
Featured trial
A 26 week, randomized, active-controlled safety study of a double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus and inhaled corticosteroid in adolescent and adult patients with persistent asthma.

A 26 week, randomized, active-controlled safety study of a double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus and inhaled corticosteroid in adolescent and

  • 254 views
  • 23 Nov, 2020
  • 1 location
The Efficacy of Budesonide/Formoterol in Cough Variant Asthma

ICS/LABA for 3 months. Overall, the best treatment of CVA is not yet clear. GINA 2018 emphasize that asthma need long-term management. Euro-SMART study found that budesonide/formoterol 2

  • 14 views
  • 24 Jan, 2021
  • 1 location
Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial (FORZA)

Randomized, double-blind, placebo-controlled study comparing formoterol-beclometason 12/200 mcg BID versus placebo to evaluate the clinical effect on coughing in patients with non-cystic

high resolution computed tomography
pulmonary disease
fibrosis
beclomethasone
macrolides
  • 0 views
  • 10 Apr, 2022
  • 3 locations
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.

  • 0 views
  • 21 Apr, 2022
  • 4 locations
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis

WHO recommend to divide AR into 4 subgroups according to the symptom frequency (intermittent or persistent) and severity (mild or moderate-to-severe). For the persistent moderate-to-severe AR subgroup, the guideline suggests to treat with intranasal corticosteroid (INS) plus antihistamines (AH1) for 2-4 weeks. If the symptom is controlled then degrade the …

  • 0 views
  • 11 May, 2022
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient

The purpose of the study is to demonstrate the Pharmacodynamic bioequivalence of the test product to the reference product in adult patient with Asthma

  • 0 views
  • 23 May, 2022
  • 1 location
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) (VATHOS)

This is a 24 week study to evaluate the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma.

  • 11 views
  • 17 Jun, 2022
  • 73 locations
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) (KALOS)

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with

  • 126 views
  • 19 Jun, 2022
  • 240 locations